Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
KYLYS Logo
KYLYS Growth Score
62
CB Rank
171904
Heat Score
71
KYLYS provides people and patients with highly effective and safe products based on biomolecules.
Founded
obfuscation
PrivateDebt Financing Plan-les-ouates, Geneve, Switzerland1-10 kylys.com
Biotechnology
Life Science
Medical
Pharmaceutical
Overview

KYLYS
Total Funding
obfuscation
Growth Score
62
Heat Score
71

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score62
-27 pts
in past quarter
Heat Score 71
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About KYLYS

CB Rank
171904
KYLYS provides people and patients with highly effective and safe products based on biomolecules.
Founded
obfuscation
PrivateDebt Financing Plan-les-ouates, Geneve, Switzerland1-10 kylys.com
Biotechnology
Life Science
Medical
Pharmaceutical

Funding Rounds

Debt Financing
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name KYLYS Sarl
Operating Status Active
Company Type For Profit
Founders  Olivier Jordan
About the Company
KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HA-L-PNIPAM
A biocompatible and biodegradable hyaluronic acid-based gel that forms microgel structures at body temperature for prolonged tissue presence and reduced migration.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing
obfuscation
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
1
obfuscation
FONGITDebt Financing

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
FONGIT Logo
FONGIT
Yes
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
—
FONGIT Logo
FONGIT
Yes
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
—
FONGIT Logo
FONGIT
Yes
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
—
FONGIT Logo
FONGIT
Yes
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
—
FONGIT Logo
FONGIT
Yes
Debt Financing - KYLYS Logo
Debt Financing - KYLYS
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•May 6, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

70
-65.35%
 in past month

IT Spend

$272.8KThis year, KYLYS is projected to spend $272.8K on IT, according to Aberdeen.

Active Website Tech Count

2KYLYS is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is KYLYS's headquarters? KYLYS is located in Plan-les-ouates, Geneve, Switzerland.Who invested in KYLYS? KYLYS has 2 investors including FONGIT and  Eclosion SA.When was the last funding round for KYLYS? KYLYS closed its last funding round on
obfuscation
from a Debt Financing round.Who are KYLYS's competitors? Alternatives and possible competitors to KYLYS may include Galderma, Huons, and  Allergan Aesthetics.How much funding has KYLYS raised to date? KYLYS has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|